Načítá se...
Detection of Pan drug resistance OXA-48 producing Providencia in an ICU patient for the first time in Nepal
BACKGROUND: Resistance to antimicrobial agents of pathogenic bacteria has become a major problem in routine medical practices. Carbapenem resistance has long been increasing. The production of carbapenem- hydrolysing β-lactamases (carbapenamases), which include NDM, KPC, OXA-48, IMP-1 and VIM is the...
Uloženo v:
| Vydáno v: | Antimicrob Resist Infect Control |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6794824/ https://ncbi.nlm.nih.gov/pubmed/31636898 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13756-019-0608-1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|